FDA Proposes Drug-Facility Rules to Improve Supply-Chain Visibility
A proposed FDA rule would give regulators more information on distributed drug makers and certain foreign suppliers, but patients and pharmacies see no immediate change.
A proposed FDA rule would give regulators more information on distributed drug makers and certain foreign suppliers, but patients and pharmacies see no immediate change.